B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)

REACTOME PATHWAY
Reactome: R-HSA-56190992 genes12 compounds

The Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) pathway (Reactome ID: R-HSA-5619099) involves 2 genes and is affected by 12 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

AVPR1AAVPR1B

Compounds Affecting Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)

#CompoundTargets HitStudies
1Arginine Vasopressin298
2Oxytocin299
3Deamino Arginine Vasopressin46
4Ornipressin82
5Lypressin24
6Amdinocillin100
7Aripiprazole298
8Astemizole Antihistamine drug now withdrawn from280
9Calcimycin216
10Daunorubicin298
11Ritonavir298
122-Chloroadenosine 2-Chloroadenosine.300

About the Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) Pathway

The Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) pathway is catalogued in Reactome (ID: R-HSA-5619099) and involves 2 genes. In the BiohacksAI corpus, 12 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include AVPR1A, AVPR1B.